Stem Cells and Intervertebral Disc Regeneration Overview-What They Can and Can't Do
- PMID: 34376495
- PMCID: PMC8092931
- DOI: 10.14444/8054
Stem Cells and Intervertebral Disc Regeneration Overview-What They Can and Can't Do
Abstract
Background: Low back pain (LPB) is the main cause of disability worldwide with enormous socioeconomic burdens. A major cause of LBP is intervertebral disc degeneration (IDD): a chronic, progressive process associated with exhaustion of the resident cell population, tissue inflammation, degradation of the extracellular matrix and dehydration of the nucleus pulposus. Eventually, IDD may lead to serious sequelae including chronic LBP, disc herniation, segmental instability, and spinal stenosis, which may require invasive surgical interventions. However, no treatment is actually able to directly tackle IDD and hamper the degenerative process. In the last decade, the intradiscal injection of stem cells is raising as a promising approach to regenerate the intervertebral disc. This review aims to describe the rationale behind a regenerative stem cell therapy for IDD as well as the effect of stem cells following their implantation in the disc environment according to preclinical studies. Furthermore, actual clinical evidence and ongoing trials will be discussed, taking into account the future perspective and current limitations of this cutting-edge therapy.
Methods: A literature analysis was performed for this narrative review. A database search of PubMed, Scopus and ClinicalTrials.gov was conducted using "stem cells" combined with "intervertebral disc", "degeneration" and "regeneration" without exclusion based on publication date. Articles were firstly screened on a title-abstract basis and, subsequently, full-text were reviewed. Both preclinical and clinical studies have been included.
Results: The database search yielded recent publications from which the narrative review was completed.
Conclusions: Based on available evidence, intradiscal stem cell therapy has provided encouraging results in terms of regenerative effects and reduction of LBP. However, multicenter, prospective randomized trials are needed in order confirm the safety, efficacy and applicability of such a promising treatment.
Keywords: disc regeneration; intervertebral disc degeneration; intradiscal injection; mesenchymal stem cells; stem cell.
This manuscript is generously published free of charge by ISASS, the International Society for the Advancement of Spine Surgery. Copyright © 2021 ISASS.
Conflict of interest statement
Figures
Similar articles
-
Differentiation of Pluripotent Stem Cells into Nucleus Pulposus Progenitor Cells for Intervertebral Disc Regeneration.Curr Stem Cell Res Ther. 2019;14(1):57-64. doi: 10.2174/1574888X13666180918095121. Curr Stem Cell Res Ther. 2019. PMID: 30227822 Review.
-
What is the clinical evidence on regenerative medicine in intervertebral disc degeneration?Musculoskelet Surg. 2017 Aug;101(2):93-104. doi: 10.1007/s12306-017-0462-3. Epub 2017 Feb 13. Musculoskelet Surg. 2017. PMID: 28191592 Review.
-
Mesenchymal stem cells for intervertebral disc regeneration.J Biol Regul Homeost Agents. 2016 Oct-Dec;30(4 Suppl 1):173-179. J Biol Regul Homeost Agents. 2016. PMID: 28002916 Review.
-
Intradiscal Mesenchymal Stromal Cell Therapy for the Treatment of Low Back Pain Due to Moderate-to-Advanced Multilevel Disc Degeneration: A Preliminary Report of a Double-Blind, Phase IIB Randomized Clinical Trial (DREAM Study).JOR Spine. 2025 Jun 2;8(2):e70086. doi: 10.1002/jsp2.70086. eCollection 2025 Jun. JOR Spine. 2025. PMID: 40462867 Free PMC article.
-
Growth and differentiation factor-5 contributes to the structural and functional maintenance of the intervertebral disc.Cell Physiol Biochem. 2015;35(1):1-16. doi: 10.1159/000369670. Epub 2015 Jan 2. Cell Physiol Biochem. 2015. PMID: 25547527 Review.
Cited by
-
Lumbar disc herniation reabsorption: a review of clinical manifestations, mechanisms, and conservative treatments.Front Med (Lausanne). 2025 Jul 28;12:1633762. doi: 10.3389/fmed.2025.1633762. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40792301 Free PMC article. Review.
-
Allogenic bone marrow-derived mesenchymal stromal cell-based therapy for patients with chronic low back pain: a prospective, multicentre, randomised placebo controlled trial (RESPINE study).Ann Rheum Dis. 2024 Oct 21;83(11):1572-1583. doi: 10.1136/ard-2024-225771. Ann Rheum Dis. 2024. PMID: 39393844 Free PMC article. Clinical Trial.
-
Comprehensive narrative review on the analysis of outcomes from cell transplantation clinical trials for discogenic low back pain.N Am Spine Soc J. 2022 Dec 22;13:100195. doi: 10.1016/j.xnsj.2022.100195. eCollection 2023 Mar. N Am Spine Soc J. 2022. PMID: 36655116 Free PMC article.
-
Novel Magnetic Resonance Imaging Tools for the Diagnosis of Degenerative Disc Disease: A Narrative Review.Diagnostics (Basel). 2022 Feb 6;12(2):420. doi: 10.3390/diagnostics12020420. Diagnostics (Basel). 2022. PMID: 35204509 Free PMC article. Review.
-
Preclinical to clinical translation for intervertebral disc repair: Effects of species-specific scale, metabolism, and matrix synthesis rates on cell-based regeneration.JOR Spine. 2023 Sep 7;6(3):e1279. doi: 10.1002/jsp2.1279. eCollection 2023 Sep. JOR Spine. 2023. PMID: 37780829 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Miscellaneous